The human rights of people who use drugs must be defended

The Lancet has recently published a series of articles about drug use. More specifically, the use of opioids, cannabinoids, stimulants, and new psychoactive substances (NPS). One of these articles highlights an increasingly relevant issue of international drug policy. This comment titled Change But Not Progression, emphasises that Governments around the world continue to pedal policies  …


Response to the Nature article: Moving from prison to PhD

There are fewer than ten empirical studies on the transition from prison to university so the article “Moving from Prison to PhD” is a step in the right direction to highlight this neglected and important topic. Globally, millions of individuals are arrested and charged with drug offences every year. Most of them will be scarred  …


Response to the NICE recommendations

The National Institute for Health and Care Excellence (NICE) published their guidance to clinicians on the 11th of November 2019 regarding the prescribing of Cannabis-Based Medicinal Products (CBMPs). Drug Science welcomes this news from NICE as it shows the start of a more rational approach to medical cannabis. However, it must be emphasised that this  …


Project Twenty21

Drug Science launched Europe’s first and biggest national medical cannabis registry, called Project Twenty21, on the 7th November 2019. Project TWENTY21 will enrol 20,000 patients by the end of 2021, creating the largest body of evidence for the effectiveness and tolerability of medical cannabis – with an aim to demonstrate to policymakers that medical cannabis  …